The lipid profile in psoriasis: a controlled study
- PMID: 17958837
- DOI: 10.1111/j.1468-3083.2007.02260.x
The lipid profile in psoriasis: a controlled study
Abstract
Background: Psoriasis is an inflammatory dermatosis that is characterized with hyperproliferation of keratinocytes and inflammatory infiltration in the epidermis and dermis. The high prevalence of atherosclerosis has been reported in psoriatic patients. High serum lipid level has been suggested in the pathogenesis of this phenomenon. In this study, our purpose was to compare the lipid profile in psoriatic patients with non-affected persons.
Methods: This study was designed and conducted as a case-control assay with 50 cases in the patient and control groups, respectively. The lipid profile, including serum level of triglyceride, cholesterol, low-density lipoprotein (LDL), and high-density lipoprotein (HDL), were assessed in both groups.
Results: The patient and control groups each consisted of 50 cases (39 male and 11 female). The serum triglyceride, cholesterol, and LDL was significantly higher in psoriatic patients (P < 0.05) but not for HDL (P = 0.29).
Conclusion: This study, like previous assays, shows that high serum lipid level is significantly more common in psoriasis. This fact may be responsible for higher prevalence of cardiovascular accident in psoriatic patients. It may be useful to do early screening and treatment of hyperlipidaemia in psoriasis to prevent the atherosclerosis and its complications.
Similar articles
-
Lipid disturbances in psoriasis: an update.Mediators Inflamm. 2010;2010:535612. doi: 10.1155/2010/535612. Epub 2010 Jul 20. Mediators Inflamm. 2010. PMID: 20706605 Free PMC article. Review.
-
Serum lipid level in Iraqi patients with psoriasis.Skinmed. 2010 Jul-Aug;8(4):204-6. Skinmed. 2010. PMID: 21137604
-
Serum lipid level in Iranian patients with psoriasis.J Eur Acad Dermatol Venereol. 2007 Jul;21(6):802-5. doi: 10.1111/j.1468-3083.2006.02099.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17567311
-
Activity of serum lipase [EC 3.1.1.3] and the diversity of serum lipid profile in psoriasis.Med Sci Monit. 2002 Jan;8(1):CR9-CR13. Med Sci Monit. 2002. PMID: 11782673
-
Cardiovascular aspects of psoriasis: an updated review.Int J Dermatol. 2013 Feb;52(2):153-62. doi: 10.1111/j.1365-4632.2012.05584.x. Int J Dermatol. 2013. PMID: 23347301 Review.
Cited by
-
Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients.Arch Dermatol Res. 2017 Mar;309(2):79-86. doi: 10.1007/s00403-016-1709-9. Epub 2016 Dec 17. Arch Dermatol Res. 2017. PMID: 27988894 Free PMC article.
-
Associations between the atherogenic index of plasma and psoriasis among US adults: A cross-sectional study based on NHANES 2009 to 2014.Medicine (Baltimore). 2024 Dec 13;103(50):e40955. doi: 10.1097/MD.0000000000040955. Medicine (Baltimore). 2024. PMID: 39686463 Free PMC article.
-
Lipid disturbances in psoriasis: an update.Mediators Inflamm. 2010;2010:535612. doi: 10.1155/2010/535612. Epub 2010 Jul 20. Mediators Inflamm. 2010. PMID: 20706605 Free PMC article. Review.
-
Psoriasis and metabolic disease: epidemiology and pathophysiology.Curr Opin Rheumatol. 2008 Jul;20(4):416-22. doi: 10.1097/BOR.0b013e3283031c99. Curr Opin Rheumatol. 2008. PMID: 18525354 Free PMC article. Review.
-
Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature.J Gen Intern Med. 2011 Sep;26(9):1036-49. doi: 10.1007/s11606-011-1698-5. Epub 2011 Apr 7. J Gen Intern Med. 2011. PMID: 21472501 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical